Unmet Need
Prostate cancer is the most common non-cutaneous malignancy. Additionally, it is the second leading cause of cancer related deaths among men in the United States with nearly 1 in every 6 men predicted to be diagnosed with the disease at some point in their lives. Currently, the most common biopsy method is a transrectal ultrasound (TRUS)...
Unmet Need
An estimated 233,00 new cases of prostate cancer were diagnosed in the US alone. Studies have shown it is necessary to treat many men to prevent one death from prostate cancer. However, the current method of biopsy often misses relevant tumors. Accordingly, there is a need for more specific prostate screening test and more reliable prostate...
C11934: Robot-guided Prostate Biopsy
Novelty:
This technology is a novel transrectal ultrasound method and probe for prostate biopsy.
Value Proposition:
Prostate cancer is the most frequently diagnosed non-skin malignancy for men in the U.S. Treatment and monitoring methods rely heavily on biopsy. Current transrectal ultrasound-guided (TRUS)...
C11305: Remote Center of Motion Robot for Medical Image Scanning and Image-guided Targeting
Novelty:
A robot which uses a Remote Center of Motion to operate ultrasound probes with maneuverability similar to manual handling. It allows 3-D image rendering from 2-D ultrasound and enables a variety of robot-assisted image-guided procedures.
Value...
